JAMA Oncology · 12 Nov 2026
Integrating Chemotherapy With Immunotherapy Prior to Surgery for Patients With Locally Advanced HNSCC
Mina Bakhtiar, Ravindra Uppaluri, Jonathan D. Schoenfeld
0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
6
References
works it cites, from open citation data
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
No abstract is available for this paper.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
0 shown
No citing papers for this filter.
References (6)
What it cites, from open citation data, with Crossref's record of each.
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
532Journal of Clinical Oncology · 2023
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
488New England Journal of Medicine · 2025
Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
157Clinical Cancer Research · 2022
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
46Nature Reviews Clinical Oncology · 2024
Neoadjuvant Nivolumab plus Carboplatin and Paclitaxel in Patients with Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck: A Phase II, Single-Arm Trial
4Clinical Cancer Research · 2025